News
CLL and breast cancer differ in the expression of regulatory microRNAs
A particular microRNA was found to be associated with prevascular invasion.
News
Webinar confronts unique issues for the bleeding disorders community facing COVID-19
Patients in gene therapy trials and those with factor inhibitors are of particular concern.
News
AGA and colleague societies issue clinical insights for COVID-19
Screening patients, personal protection, procedure postponement, and special precautions with infected patients are discussed.
News
Follicular lymphoma treatment can benefit patients 80 years and older
FL-directed therapy was associated with an overall survival benefit, which persisted.
News
COVID-19: ASTCT provides interim guidelines for transplantation
The American Society for Transplantation and Cellular Therapy document focuses on patient-treatment specifics and donor issues.
News
Sickle cell patients with vitamin D deficiency prone to more ED visits, longer stays
Screening for vitamin D deficiency may show benefits, authors suggest.
News
Accelerated fetal growth in boys associated with development of AML
The correlation was seen especially in infant boys and those with minimally differentiated leukemia.
News
Fracture risk for MM patients remains higher despite improvements in treatments, survival
Despite new treatment strategies there was no decreased fracture risk for multiple myeloma patients over time.
News
NMA haploidentical allo-BMT plus post-transplant cyclophosphamide deemed safe, effective for CLL
Patients with less than 20% marrow CLL involvement before transplant had an improved 4 year survival.
News
Chimerism and the use of fludarabine associated with secondary graft failure in aplastic anemia
News
Monthly injection therapy for HIV found noninferior to daily oral dosing
Injections of long-acting suspensions of cabotegravir and rilpivirine show promise for the control of HIV.
News
New CAR T-cell therapy eliminates MM and tumor propagating cells without fratricide in lab study
CD229 CAR T cells are highly active in vitro and in vivo against multiple myeloma plasma cells, memory B cells, and MM-propagating cells.
Opinion
ID Blog: SARS-CoV-2 – What’s in a name?
From “Wuhan virus” to “novel coronavirus-2019” to “COVID-19 virus” to “SARS-CoV-2,” the process of naming is complex and even risky to public...